What does PA — tenant improvement reimbursements mean?

The amount of money a landlord pays back to the company for building improvements in a leased space.

How do you interpret PA — tenant improvement reimbursements?

An increase indicates successful negotiation of tenant incentives, reducing the net capital burden on the company.

How does PA — tenant improvement reimbursements compare across companies?

Common in biotech firms with significant R&D laboratory footprints; peers often report this as a reduction in net leasehold improvement costs.

Cytokinetics CYTK PA — Tenant Improvement Reimbursements

Discontinued — last reported Q4 '22

Similar metrics at other companies

ARWRCalifornia — Proceeds From Tenant Improvement Allowance

$3.1M0.0%

MRNACambridge leases — Allowance for tenant improvements

$3.5M—

SYRETX — Tenant Improvements

$200K—

CACILandlord sponsored tenant incentives

$2.72M+171%

ARWRCalifornia — Payments for leasehold improvements, net of tenant improvement allowances

$32M+700%

ARWRCA — Expected Payments Of Leasehold Improvements Net Of Tenant Improvement Allowances

$4.2M—

Other financials

Income statement

See full

Revenue$19.4M+1,126%

Operating income-$183.6M-18.0%

Net income-$206.0M-27.7%

EPS (diluted)-$1.67-22.8%

Balance sheet

See full

Cash & equivalents$129.8M+76.2%

Total debt$418.2M+75.8%

Total equity-$826.6M-210%

Total assets$1.3B+0.7%

Cash flow

See full

Operating cash flow-$145.5M-10.5%

CapEx$5.9M+4.7%

Free cash flow-$151.4M-10.3%

Valuation

See full

Market cap$10.7B+70.6%

Enterprise value$10.98B+70.7%

P/S101.1×-225×

Profitability

See full

Operating margin-605.1%-268pp

Net margin-784%-337pp

FCF margin-518.8%-223pp

Returns & leverage

See full

Return on equity-337.6%—

Debt / equity2.2×—

Current ratio4.2×-1.8×

Where this comes from

Reported directly by Cytokinetics in its filing.

Tagged under the XBRL concept cytk:TenantImprovementReimbursements.

The official record: Cytokinetics’s 10-K, filed March 1, 2023, on SEC EDGAR. View the filing →

Ask your AI about Cytokinetics's pa — tenant improvement reimbursements.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Cytokinetics's PA — tenant improvement reimbursements?: Cytokinetics (CYTK) reported PA — tenant improvement reimbursements of $300K in Q4 2022.
What does PA — tenant improvement reimbursements mean?: The amount of money a landlord pays back to the company for building improvements in a leased space.
How do you interpret PA — tenant improvement reimbursements?: An increase indicates successful negotiation of tenant incentives, reducing the net capital burden on the company.
How does PA — tenant improvement reimbursements compare across companies?: Common in biotech firms with significant R&D laboratory footprints; peers often report this as a reduction in net leasehold improvement costs.